Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- Publicado em
- 6 jul 2022
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire
Allassane F Ouattara, Catherine M Bjerum, Méité Aboulaye, Olivier Kouadio, Vanga K Marius, Britt Andersen, Daphne Lew, Charles W Goss, Gary J Weil, Benjamin G Koudou et al.
Descritores MeSH
- Elephantiasis, Filarial
- Filaricides
- Albendazole
- Adult
- Ivermectin
- Cote d'Ivoire
- Wuchereria bancrofti
- Humans
- Animals
- Diethylcarbamazine
Veja também
Estudos relacionados
- Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial
- Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study
- Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial
- Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial